NCT01107028

Brief Summary

Idiopathic pulmonary fibrosis (IPF) is a devastating disease marked by progressive lung scarring leading to multiple life-altering sequelae. The over-arching goals of the principal investigator's research program are to more fully characterize these sequelae and to examine interventions that might improve them. The hypotheses of this particular study are that pulmonary rehabilitation (PR) is one such intervention, and that PR will improve the sequelae of dyspnea and impairments in functional capacity, cognition, mood and anxiety, fatigue, and quality of life (QOL) in patients with IPF.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 16, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 20, 2010

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
Last Updated

October 22, 2020

Status Verified

October 1, 2020

Enrollment Period

4.7 years

First QC Date

April 16, 2010

Last Update Submit

October 19, 2020

Conditions

Keywords

Idiopathic pulmonary fibrosisDyspneaFunctional capacityQuality of life

Outcome Measures

Primary Outcomes (1)

  • Six-minute walk distance

    Distance walked during a standard six-minute walk test.

    Eight weeks

Secondary Outcomes (3)

  • dyspnea, fatigue, anxiety, depression, quality of life

    Eight weeks

  • Six minute walk distance

    Six months after completion of pulmonary rehabilitation

  • dyspnea, fatigue, anxiety, depression, quality of life

    Six months after completion of pulmonary rehabilitation

Study Arms (2)

Rehab

Subjects randomized to the Rehab group will have data collected at baseline and then within one week enroll in a pulmonary rehabilitation program. Data will again be collected within one week of completing pulmonary rehabilitation and again six months later.

Other: Standard pulmonary rehabilitation program

Wait

Subjects randomized to the Wait group will have data collected at baseline and wait eight weeks before enrolling in a pulmonary rehabilitation program. Data will again be collected within one week of completing pulmonary rehabilitation and again six months later.

Other: Standard pulmonary rehabilitation program

Interventions

At the assigned time, subjects will complete a six-week, outpatient pulmonary rehabilitation program at any local center that has such a program.

RehabWait

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Idiopathic pulmonary fibrosis, as defined by the American Thoracic Society Consensus Guidelines

You may qualify if:

  • Age \> 40 years
  • IPF
  • Able to walk unassisted for balance
  • Able to speak and understand English well enough to complete complex tasks with directions given in English

You may not qualify if:

  • Pulmonary fibrosis not due to IPF
  • Coexisting comorbid conditions that would make exercise contraindicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Jewish Health

Denver, Colorado, 80206, United States

Location

Related Publications (1)

  • Swigris JJ, Brown KK, Make BJ, Wamboldt FS. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med. 2008 Dec;102(12):1675-80. doi: 10.1016/j.rmed.2008.08.014. Epub 2008 Oct 10.

    PMID: 18848771BACKGROUND

MeSH Terms

Conditions

Idiopathic Pulmonary FibrosisDyspnea

Condition Hierarchy (Ancestors)

Pulmonary FibrosisLung Diseases, InterstitialLung DiseasesRespiratory Tract DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jeffrey J. Swigris, DO, MS

    National Jewish Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2010

First Posted

April 20, 2010

Study Start

February 1, 2010

Primary Completion

October 1, 2014

Study Completion

October 1, 2014

Last Updated

October 22, 2020

Record last verified: 2020-10

Locations